Combretastatins for prevention of posterior capsule opacification

Details for Australian Patent Application No. 2010266109 (hide)

Owner Oxigene, Inc.

Inventors Quinlan, Roy; Tholozan, Frederique

Agent Cullens

Pub. Number AU-A-2010266109

PCT Pub. Number WO2011/003080

Priority 61/222,841 02.07.09 US

Filing date 2 July 2010

Wipo publication date 6 January 2011

International Classifications

C07F 9/02 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/003080 Priority application(s): WO2011/003080

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010266114-HYR1 as a target for active and passive immunization against Candida

2010266105-Soluble alternating donor-acceptor conjugated polymer electrochromes